Clinical Trials for CDKL5 and Related Disorders

CDKL5 South Asia Foundation supports families by coordinating recruitment for the CDKL5 Gene Therapy Clinical Trial Recruitment Programand sharing information about other ongoing clinical trials that may be relevant to the CDKL5 community, including the CDKL2 Clinical Trial.

CDKL5 Gene Therapy Clinical Trial Recruitment

CDKL5 South Asia Foundation is coordinating recruitment for the CDKL5 Gene Therapy Clinical Trial Recruitment Program. Applications submitted through this form will be reviewed to determine whether the patient may meet the preliminary inclusion and exclusion criteria.

Families whose patients appear to meet the preliminary eligibility requirements may be contacted regarding the next stage of the screening process.

Submission of this application does not guarantee eligibility, selection, or enrolment into the clinical trial.

Other Clinical Trials

CDKL2 Clinical Trial

The CDKL2 Clinical Trial is another important clinical program involving a gene from the same family as CDKL5. CDKL5 South Asia Foundation shares this information to keep families informed about significant advances in related genetic neurological disorders.

Learn More About the CDKL2 Clinical Trial →

CDKL5 Gene Therapy Clinical Trial Recruitment Application

Complete this application to help CDKL5 South Asia Foundation evaluate the patient’s potential eligibility for the CDKL5 Gene Therapy Clinical Trial Recruitment Program.

Applicant

Parent Details

Patient Details

Patient Name *

Patient Date of Birth *

Location

Clinical Trial Eligibility

Has genetic testing been completed? *

Is the genetic report available? *

Would you like the patient to be considered for participation in the CDKL5 Gene Therapy Clinical Trial Recruitment Program coordinated by CDKL5 South Asia Foundation, subject to meeting the trial eligibility criteria? *

Additional Information

Please share any additional medical information, current therapies, seizure history, or anything else that may help us understand patient's current condition.

Your information will be kept strictly confidential and will only be used by CDKL5 South Asia Foundation to evaluate eligibility for the CDKL5 Gene Therapy Clinical Trial Recruitment Program and communicate updates related to this program.

I understand that this registration expresses my interest only and does not guarantee enrolment into a clinical trial. I consent to CDKL5 South Asia Foundation securely storing my information and contacting me regarding this Clinical Trial Recruitment Program and related screening activities

Frequently Asked Questions

Who can apply?

Parents, legal guardians, or primary caregivers of patients diagnosed with CDKL5 Deficiency Disorder.

Does submitting this application guarantee participation?

No. Every application is reviewed against the study's eligibility criteria before families are contacted.

What happens after I submit the application?

Our team will review the information provided to determine whether the patient may meet the preliminary eligibility criteria. Families may then be contacted regarding the next stage of screening.

Will my information remain confidential?

Yes. Information submitted through this application is kept confidential and used only for evaluating eligibility and communicating updates related to the Clinical Trial Recruitment Program.